With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 ...

PANOVA-3: Phase 3 study of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel for locally advanced pancreatic ductal adenocarcinoma (LA-PAC).. If you have the appropriate software ...

Aardvark Therapeutics, Inc. announced progress in its Phase 3 HERO trial for ARD-101, aimed at treating hyperphagia associated with Prader-Willi Syndrome, with data expected in early 2026.

Read about the Space Force's addition of Rocket Lab and Stoke Space to the National Security Space Launch Phase 3 Lane 1 contract under the first on-ramp.

A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary endpoint. But, having made a second-generation molecule its lead candidate last year, the biotech isn’t currently ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that the Kyowa Kirin-partnered rocatinlimab improves outcomes in atopic ...

General Pump Company (“GPC”), the number one provider of utility-scale water well and pump services for Southern California’s most critical water infr ...

The phase 3 waveLINE-010 trial is evaluating zilovertamab vedotin plus R-CHP vs R-CHOP for the treatment of untreated diffuse large B-cell lymphoma.

The development of a well-tuned motor control system can be a complex and time-consuming activity that involves many different hardware and software pieces.

Whereas Part 1 of this three-part installment covered connections to and power sources for fire pumps (August 2024), and Part 2 dealt with disconnecting means, overcurrent protection, and transformers ...

In the first installment of this three-part series of articles, featured in the August 2024 print issue and online, we discussed fire pump requirements along with Code-related references in the ...

The DEEp SEA Study (LP352-302) is a global Phase 3 double-blind, placebo-controlled clinical trial to evaluate the efficacy of bexicaserin in Dravet syndrome as assessed by countable motor ...